Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
July 26, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for December 8, 2004 Subscribe to this News Feed      
 

National Leadership Forum to Focus on Methamphetamine

Anti-Drug Coalition leaders to meet in Washington, D.C. and discuss methamphetamine abuse and prevention along with other drugs

(PRWEB) December 8, 2004 -- Methamphetamine is one of the nations fastest growing drugs of abuse and now more than a million Americans are addicted to the highly debilitating substance. Due to the increased prevalence throughout the U.S., meth use and manufacturing will be a featured topic at the upcoming National Leadership Forum hosted by the Community Anti-Drug Coalitions of America (CADCA) in Washington, D.C. early next month.

The Consumer Healthcare Products Association developed a program called Meth Watch to target the sales and theft of pseudoephedrine, which is the main ingredient in methamphetamine. Originating in Kansas, the program now operates in a dozen states and helps with meth lab seizures, prevents small meth lab production as well as the theft of pseudoephedrine and joins retailers and law enforcement in a collaborative effort.

The overall number of meth lab busts has increased exponentially across the nation in recent years. The number of meth labs found and dismantled has doubled and in some states tripled over the previous year. An alarming number of the individuals that have been arrested and convicted for meth manufacturing and distribution are repeat offenders. Also alarming is the high recidivism rate of meth addicts in recovery. Some treatment providers report as high as 90% of the meth addicts in treatment programs relapse after completion.

Drug rehabilitation programs in general are having a difficult time in effectively dealing with methamphetamine addiction. However, there is one organization that is rapidly gaining national attention for its effectiveness in treating meth addiction is Narconon Arrowhead. Narconon attributes its success to the organizations use of the drug-free rehabilitation technology researched and developed by American author and humanitarian L. Ron Hubbard. Narconons approach replaces vital nutrients stripped by drug use, dry-heat sauna detoxification therapy and a series of life skills courses that assists addicts in regaining their self respect and teaches them how lead a productive drug-free life and rejoin society as contributing members.

There are hundreds of former meth addicts that are now living healthy lives again due to completing the program at Narconon Arrowhead. To find out more about meth or the Narconon® Drug Rehabilitation and Education Program, call 1-800-468-6933 today or log on to www.methamphetamineaddiction.com.

# # #

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
Email this story to a colleague
CONTACT INFORMATION
Luke Catton
NARCONON ARROWHEAD
918-339-5821
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright